
Rajshekhar Chakraborty, MD, discusses the safety and tolerability of linvoseltamab with carfilzomib when used for the treatment of patients with relapsed/refractory multiple myeloma.

Your AI-Trained Oncology Knowledge Connection!

Rajshekhar Chakraborty, MD, works in the Department of Medicine at Columbia University Irving Medical Center, New York, NY.